Use of hepatitis B core antibody-positive donors in recipients without evidence of hepatitis B infection: A survey of current practice in the United States

Liver Transplantation

Volumn 9, Issue 8, 2003, Pages 837-842

  Burton Jr , James R ^a   Shaw Stiffel, Thomas A ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; LAMIVUDINE; VIRUS DNA;

ANTIBODY DETECTION; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DNA DETERMINATION; HEALTH SURVEY; HEPATITIS B; HUMAN; IMMUNOPROPHYLAXIS; INFECTION RISK; LIVER TRANSPLANTATION; LIVING DONOR; MEDICAL RECORD; PRIORITY JOURNAL; QUESTIONNAIRE; SERODIAGNOSIS; UNITED STATES; VIRUS REACTIVATION; VIRUS TRANSMISSION;

EID: 0043064160     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50157     Document Type: Article

References (30)

1. United Network For Organ Sharing. Current US waiting list as of December 13, 2002. Available at http://www.unos.org. Accessed January 2, 2003.
2. Hadler SC, Murphy BL, Schable CA, Heyward WL, Francis DP, Kane MA. Epidemiological analysis of the significance of low positive test results for antibody to hepatitis B surface and core antigens. J Clin Microbiol 1984:19;521-525.
3. Joller-Jemelka HI, Wicki AN, Grob PJ. Detection of HBs antigen in "anti-HBc alone" positive sera. J Hepatol 1994;21:269-272.
4. Dickson RC, Everhart JE, Lake JR, Wei Y, Seaberg EC, Wiesner RH, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology 1997;113:1668-1674.
5. Dodson SF, Issa S, Araya V, Gayowski T, Pinna A, Eghtesad B, et al. Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation 1997;64:1582-1584.
6. Lok ASF, Lai CL, Wu PC. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: Implication in hepatitis B vaccination programs. Hepatology 1988;8:766-770.
7. Prieto M, Gomez MD, Berenguer M, Cordoba J, Rayon JM, Pastor M, et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl 2001;7:51-58.
8. McQuillan G, Coleman P, Kruszon-Moran D, Moyer L, Lambert S, Margolis H. Prevalence of hepatitis B virus infection in the United States: The National Health and Nutrition Examination Survey, 1976 through 1994. Am J Public Health 1999; 89:14-18.
9. Katchaki JH, Seim TIY, Brouwer R, Brandt KH, van der Waart M. Detection and significance of anti-HBc in the blood bank: Preliminary results of a controlled prospective study. J Virol Methods 1980;2:119-125.
10. Larsen J, Hetland G, Skaug K. Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative virus carrier. Transfusion 1990;20:431-432.
11. Koziol DE, Holland PV, Alling DW, Melpolder JC, Solomon RE, Purcell RH, et al. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986;104:488-495.
12. -) organ donors. Transplantation 1995;59: 230-234.
13. Douglas DD, Rakela J, Wright TL, Krom RA, Wiesner RH. The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient. Liver Transpl Surg 1997;3:105-111.
14. Muñoz S. Use of hepatitis B core antibody-positive donors for liver transplantation. Liver Transpl 2002;8(suppl):S82-S87.
15. Chung RT, Feng S, Delmonico FL. Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor. Am J Transplant 2001;1:185-191.
16. Conjeevaram HS, Lok AS. Occult hepatitis B infection: A hidden menace. Hepatology 2001;34:204-206.
17. Roque-Afonso AM, Feray C, Samuel D, Simoneau D, Roche B, Emile JF, et al. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver graft from anti-HBc positive donors. Gut 2002;50:95-99.
18. Manzarbeitia C, Reich DJ, Ortiz JA, Rothstein KD, Araya VR, Munoz SJ. Safe use of livers from donors with positive hepatitis B core antibody. Liver Transpl 2002;8:556-561.
19. Fabia R, Levy M, Crippin J, Tillery W, Netto G, Aguanno J, et al. De novo hepatitis B infection after liver transplantation: Source of disease, incidence, and impact. Liver Transpl Surg 1998;4:119-127.
20. Uemoto S, Sugiyama K, Marusawa H, Inamata Y, Asonuma K, Egawa H, et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living-related liver transplant. Transplantation 1998;65;494-499.
21. Crespo J, Fabraga E, Casafont F, Rivero M, de las Heras G, de la Peña J, et al. Severe clinical course of de novo hepatitis B infection after liver transplantation. Liver Transpl Surg 1999;5:175-183.
22. Roche B, Samuel D, Gigou M, Feray C, Virot V, Schmets L, et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol 1997;26:517-526.
23. Segovia R, Sánchez-Fueyo A, Rimola A, Grande L, Bruguera M, Costa J, et al. Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation. Liver Transpl 2001;7:106-112.
24. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993;329:1842-1847.
25. Shouval D, Samuel D. Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: A concise review. Hepatology 2000;32:1189-1195.
26. Markowitz JS, Martin P, Conrad AJ, Markmann JF, Seu P, Yersiz H, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology 1998;28:585-589.
27. Yu AS, Vierling JM, Colquhoun SD, Arnaout WS, Chan CK, Khanafshar E, et al. Transmission of hepatitis B infection from hepatitis B core antibody-positive liver allografts is prevented by lamivudine therapy. Liver Transpl 2001;7:513-517.
28. Dodson SF, Bonham CA, Geller DA, Cacciarelli TV, Rakela J, Fung JJ. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation 1999;68:1058-1060.
29. Holt D, Thomas R, Van Thiel D, Brems JJ. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation. Arch Surg 2002;137:572-576.
30. Maguire D, Heaton ND, Smith HM. Failure of reactivation of hepatitis B after liver transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients. Transplantation 2002;73:481-482.